Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis ; volume:18 ; number:1 ; day:24 ; month:1 ; year:2020 ; pages:1-18 ; date:12.2020
Cell communication and signaling ; 18, Heft 1 (24.1.2020), 1-18, 12.2020
- Urheber
-
Neuwirt, Hannes
Bouchal, Jan
Kharaishvili, Gvantsa
Ploner, Christian
Jöhrer, Karin
Pitterl, Florian
Weber, Anja
Klocker, Helmut
Eder, Iris E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-019-0505-5
- URN
-
urn:nbn:de:101:1-2020043022493351587868
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Neuwirt, Hannes
- Bouchal, Jan
- Kharaishvili, Gvantsa
- Ploner, Christian
- Jöhrer, Karin
- Pitterl, Florian
- Weber, Anja
- Klocker, Helmut
- Eder, Iris E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Galectin-1 from cancer-associated fibroblasts induces epithelial–mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Galectin-1 from cancer-associated fibroblasts induces epithelial–mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Galectin-1 from cancer-associated fibroblasts induces epithelial–mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts